Shaojun Tan

Title: Innovations of Shaojun Tan in Biomedical Technology

Introduction

Shaojun Tan is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of biomedical technology, particularly through his innovative patents. With a total of 2 patents, his work focuses on improving drug formulations and their applications.

Latest Patents

Tan's latest patents include a crystalline form B of a tetrahydrothienopyridine compound. This invention addresses issues in prior art, such as impurities and low content, while enhancing crystalline form stability. The crystalline form B demonstrates good stability, crystallinity, and reproducibility, making it suitable for industrial production. Additionally, it exhibits a stronger anti-ADP-induced platelet aggregation effect and better fluidity. Another notable patent involves a dibromobenzyl derivative, which shows superior in-vivo pharmacokinetic stability and drug efficacy. This derivative is particularly useful for preparing respiratory drugs, especially apophlegmatic medications.

Career Highlights

Shaojun Tan is associated with Chengdu Shibeikang Biomedical Technology Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on the pharmaceutical industry.

Collaborations

Tan collaborates with notable colleagues, including Guodong Cen and Maoting Yang, to further enhance the scope and effectiveness of their research.

Conclusion

Shaojun Tan's innovative contributions to biomedical technology highlight his commitment to improving drug formulations and their applications. His patents reflect a dedication to addressing challenges in the field, paving the way for advancements in pharmaceutical development.